|
Derbeneva S.A., Pogozheva A.V., Shmeleva S.V., Sabanchieva Zh.Kh.
Unifactorial prediction of the risks of development and progression of cardiovascular diseases
|
№4 / 2024
|
|
Trofimenko I.N., Chernyak B.A.
Modern possibilities of bronchodilation therapy for patients with chronic obstructive pulmonary disease
|
№1 / 2024
|
|
Leonova M.V.
Polypills in the fight against cardiovascular diseases: a modern review of effectiveness
|
№1 / 2024
|
|
A.F. Verbovoy, N.I. Verbovaya, L.A. Sharonova
Hypothyroidism is an untimely diagnosed disease
|
№11-12 / 2022
|
|
M.B. Antsiferov (1), O.M. Koteshkova (1), M.S. Novikova (1), N.A. Demidov (2)
Possibilities of dapagliflozin in cardio-reno-metabolic protection in patients with and without type 2 diabetes mellitus
|
№12 / 2021
|
|
A.F. Verbovoy, Yu.A. Dolgikh
Insulin resistance – a common enemy for endocrinologists and cardiologists
|
№12 / 2021
|
|
D.I. Trukhan, D.S. Ivanova
Role and location of increased epithelial permeability syndrome in the development of cardiovascular and bronchopulum diseases: theoretical and practical aspects of application of rebamipide
|
№5 / 2021
|
|
N.A. Karoli, A.P. Rebrov
Beta-blockers in patients with chronic obstructive pulmonary disease: for whom, when, how?
|
№5 / 2020
|
|
V.Ya. Dzerve
ENERGY METABOLISM CORRECTOR MILDRONATE®: INTERRELATION OF MECHANISMS OF ACTION AND THERAPEUTIC EFFECTS
|
№15 / 2017
|
|
M.A. Ayrapetyan, I.G. Gordeev, N.A. Volov
GENDER FEATURES OF ACUTE CORONARY SYNDROME WITHOUT ST-SEGMENT ELEVATION
|
№9 / 2017
|
|
V.N. Shishkova
PROBLEMS OF COMORBID PATIENT AND POLYPRAGMASY IN NEUROLOGY
|
№9 / 2017
|
|
N.A. Petunina, A.L. Terekhova
ELDERLY PATIENT WITH TYPE 2 DIABETES MELLITUS: FOCUS ON ALOGLIPTIN
|
№5 / 2017
|
Русский
